Cargando…
Survival benefit of immune checkpoint inhibitor monotherapy in patients with non-small cell lung cancer recurrence after completely pulmonary resection
BACKGROUND: Selected patients in non-small cell lung cancer (NSCLC) responded to the treatment of immune checkpoint inhibitors (ICIs) have the survival benefit for advanced stages or metastatic status. METHODS: We investigated whether a response to ICI monotherapy since 2016 influences the survival...
Autores principales: | Kuroda, Hiroaki, Takahashi, Yusuke, Shirai, Suguru, Takahara, Hirotomo, Nakada, Takeo, Sakakura, Noriaki, Matsushita, Hirokazu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8421933/ https://www.ncbi.nlm.nih.gov/pubmed/34532362 http://dx.doi.org/10.21037/atm-21-1492 |
Ejemplares similares
-
Emergency rollout and conversion procedures during the three-arm robotic open-thoracotomy-view approach
por: Sakakura, Noriaki, et al.
Publicado: (2021) -
Resection of an anterior apical tumor invading the ventral first rib: a less invasive lateral thoracotomy approach
por: Sakakura, Noriaki, et al.
Publicado: (2022) -
Efficacy of Immune Checkpoint Inhibitor Monotherapy for Advanced Non-Small-Cell Lung Cancer with ALK Rearrangement
por: Oya, Yuko, et al.
Publicado: (2020) -
An extended modification of transmanubrial osteomuscular sparing approach: salvage resection for recurrent superior sulcus lung cancer after definitive chemoradiotherapy
por: Sakakura, Noriaki, et al.
Publicado: (2021) -
Clinical adjustability of radiological tools in patients with surgically resected cT1N0-staged non-small-cell lung cancer from the long-term survival evaluation
por: Kuroda, Hiroaki, et al.
Publicado: (2020)